Introduction
Recent results from large prospective studies have raised public awareness of the dangers of being overweight in middle age.' There is, however, relatively little information on the relationship of weight to mortality for older adults (age 65+ years), even though issues of how to treat patients who are overweight or underweight are of great importance. Three large population-based studies have addressed this question,>4 finding higher mortality for people with a low body mass index (BMI) and mixed results for those with a high BMI. However, the available covariate data were limited, and the statistical methods and the results also differed somewhat, as discussed below. In this paper we assess the relationship of BMI to 5-year mortality in a large cohort of currently nonsmoking older adults for whom risk factors, subclinical disease, and morbidity are well characterized.
Methods
lected from all subjects, including a home interview and clinic examination. Data collection began in 1989, and 5-year vital status is known for all subjects.6 Most of the subjects (95%) are White.
This paper examines the relationship between baseline BMI and 5-year all-cause mortality. BMI is defined as measured weight in kilograms divided by the square of measured height in meters. (Equivalently, BMI is weight in pounds divided by squared height in inches, then multiplied by 704.5.)
We chose baseline covariates that were prevalent in the elderly, were related to mortality in previous studies, and were likely to be related to BMI. Self-reported covariates include age, sex, smoking (never or former), history of cancer, fair or poor self-reported health status, 10-lb weight loss in the past year, and recalled weight at age 50. Clinical covariates include hypertension, diabetes, cardiovascular disease (prevalent heart disease, peripheral vascular disease, or cerebrovascular disease), maximum thickness of the intemal carotid artery, depression (Center for Epidemiological Studies Depression Scale), forced expira-
Data
The Cardiovascular Health Study is a population-based longitudinal study of 5201 adults 65 Table 2 is the difference between recalled weight at age 50 and measured weight at baseline (long-term weight change). The For men, the death rates were highest in the 3 lowest BMI categories, and there was a marginally significant negative linear relationship between BMI and mortality (P = .10, 2-tailed, when all variables were controlled). There was an apparent upturn in mortality for BMI greater than 32; however, there was not a significant quadratic relationship between BMI and mortality, and the mortality rate for men with a BMI greater than 32 was not significantly higher than the rate for men with a BMI between 24 and 32.
The age-adjusted mortality rates are also shown in Figure 1 with 95% confidence intervals, some ofwhich are rather large.
The bottom half of Table 3 shows mortality rates after people who had lost 10% or more of their weight after age 50 were removed from the analysis. The excess of deaths in the lowest BMI category, seen in the top half of the table, disappeared. There were no significant linear or quadratic associations between BMI and mortality.
To permit further exploration of longterm weight loss, Table 4 
Low BMI
The studies defined low BMI differently, but all found significant excess mortality in the lowest BMI group, with and without control for covariates.
High BMI
In the highest BMI group, the Framingham study found significantly elevated mortality and NHEFS found marginally elevated risk, while EPESE and CHS found no significant risk. EPESE and CHS had shorter follow-ups than the other 2 bThis category was combined with adjacent category to increase sample size.
Discussion
Our findings support those of earlier studies: that for older adults there is little relationship between BMI and mortality, except for those with a very low BMI, who have higher mortality than others.
The higher mortality found for people with the lowest BMI is often attributed to researchers' failure to control for smoking, weight loss, and preclinical disease. 19 In this study, however, low BMI was associated with mortality even after control for a wide variety of measures of baseline illness, including short-term unintended weight loss. High BMI showed no associations with mortality, despite the relationship of cardiovascular disease and other factors to both past and current weight. 20 The relatively low mortality found for older adults with a high BMI is sometimes attributed to researchers' controlling for covariates in the causal pathway. ' Another reason for differences between older and younger adults is that the nature of the disease and treatment processes that affect the middle-aged and older populations changes. The excess of chronic disease in the higher weight categories tends to decrease as lighter weight people eventually contract these diseases. '4 The total disease burden increases as the population ages, which leads to different interactions with the health care system, an increase in hospitalizations, and changes in patterns of medication use and lifestyle. The health hazards of being overweight in later life may be masked by other health risks associated with aging. '4 There are limitations to the research reported here. The Cardiovascular Health Study contains an excellent set of clinical control variables, but important factors may have been omitted. The number of subjects and deaths is reasonably large, but it did not permit us to perform detailed subgroup analyses. Analyses based on longer followup may provide different results. The study protocol excluded some of the sickest people, and we found fewer of the very thinnest men than would be expected from national statistics, suggesting that the results may not apply to the sickest or thinnest older adults. The relationship of BMI to morbidity, as opposed to mortality, also requires further study.
The interesting finding that weight at age 50 is more predictive of mortality than weight at baseline suffers from the fact that the Cardiovascular Health Study population is not a representative sample of all Americans alive at age 50, since it includes only people who survived to old age. Table  3 does not necessarily provide evidence in favor of having a low BMI at age 50. In addition, since we cannot separate out unintended long-term weight loss from intended long-term weight loss, the findings should not necessarily be taken to recommend against weight loss after age 50.
Despite the limitations of this research, we conclude that low BMI is a risk factor for 5-year mortality in older adults. However, for those who have not lost substantial weight since age 50, weight does not seem to be an important concem, perhaps because the benefits and detriments of higher weight balance out. Our findings suggest that obesity in older adults may not be a significant clinical target for reducing mortality, and that a preferred public health emphasis for this age group would be to increase awareness that substantial weight loss after age 50 and unintended weight loss are potential indicators for poor prognosis. DG
